Nuvalent Stock Revenue

NUVL Stock  USD 96.76  0.46  0.48%   
Nuvalent fundamentals help investors to digest information that contributes to Nuvalent's financial success or failures. It also enables traders to predict the movement of Nuvalent Stock. The fundamental analysis module provides a way to measure Nuvalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nuvalent stock.
Last ReportedProjected for Next Year
The value of Current Deferred Revenue is estimated to slide to about (2.4 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nuvalent Company Revenue Analysis

Nuvalent's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Historical and Projected quarterly revenue of Nuvalent

Projected quarterly revenue analysis of Nuvalent provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Nuvalent match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Nuvalent's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Nuvalent Current Deferred Revenue

Current Deferred Revenue

(2.36 Million)

The company's current value of Current Deferred Revenue is estimated at (2.36 Million)
Based on the latest financial disclosure, Nuvalent reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.

Nuvalent Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nuvalent's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nuvalent could also be used in its relative valuation, which is a method of valuing Nuvalent by comparing valuation metrics of similar companies.
Nuvalent is currently under evaluation in revenue category among its peers.

Nuvalent ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nuvalent's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nuvalent's managers, analysts, and investors.
Environmental
Governance
Social

Nuvalent Institutional Holders

Institutional Holdings refers to the ownership stake in Nuvalent that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Nuvalent's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Nuvalent's value.
Shares
Woodline Partners Lp2024-06-30
886.1 K
Geode Capital Management, Llc2024-09-30
855.6 K
Morgan Stanley - Brokerage Accounts2024-06-30
773.3 K
T. Rowe Price Associates, Inc.2024-06-30
754.1 K
Driehaus Capital Management Llc2024-06-30
696.6 K
Fred Alger Management, Llc2024-09-30
627.7 K
Wellington Management Company Llp2024-06-30
611.4 K
Pictet Asset Manangement Sa2024-06-30
568.9 K
Silverarc Capital Management, Llc2024-06-30
465.7 K
Deerfield Management Co2024-09-30
20 M
Fmr Inc2024-09-30
9.7 M

Nuvalent Fundamentals

About Nuvalent Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nuvalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nuvalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nuvalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:
Check out Nuvalent Piotroski F Score and Nuvalent Altman Z Score analysis.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.49)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.